2-Deoxy-D-Glucose – a simple anti-cancer drug is now being repurposed as adjunct therapy for emergency use in mild to moderate hospitalized Covid positive patients. Dr.Akshay Budhiraja, Pulmonologist at Aakash Healthcare, New Delhi who conducted the clinical trials said that this drug reduces the oxygen dependency by 42%, reduces the viral load and turned the CovidContinue reading “Defence Does Research and Develops Drug against Covid”
India contributes to 60-70% of global supplies of vaccines and is again set to become a hub in the Covid-19 vaccine manufacture. These are the nine Indian companies involved with the development/clinical trials/distribution/manufacture of the much awaited Covid-19 vaccines. Wish them all the best to enable protection to us from Coronavirus in 2021.
Never felt so sad and forlorn before, with the passing away of an actor, as much as I did with Soumitra Chatterjee. I think I had connected and related well with him. His debut in Satyajit Ray’s Apur Sansar had touched both my heart and mind. His portrayal of Feluda was again a sensation andContinue reading “You have given us galore Soumitrada, now rest in peace”
This must have been in the late 90s that I had met the first woman cardiologist of India Dr. Padmavati Sivaramakrishna Iyer. I remember that the Padma Vibhushan awardee had shared with me that she was born in Rangoon (then in Burma now called Myanmar) and had studied her MBBS there, before she went toContinue reading “The first woman cardiologist in India was also the oldest working physician till Covid took her life at 103”
Bharath Biotech has maintained a rather low profile since its operations in 1996. Low profile but with high productivity, because it has 160 patents to its credit and has introduced vaccines for more than a dozen diseases like Hib , Poliomyelitis, Diphtheria, Tetanus, Pertussis, H1N1, Rabies, Japanese Encephalitis, Hepatitis B, Rotavirus and Typhoid. With thisContinue reading “Mera Bharat Mahan-our nation is great. India’s first indigenous vaccine against Covid-19”